Series

COVID-19 research at Whitehead Institute

Since the start of the pandemic, several Whitehead Institute scientists have pivoted their research focus to address the biology of SARS-CoV-2 and the health impacts of COVID-19.

Covid in liver cells. Green is dsRNA, red is calreticulin, blue is nuclei stained with DAPI.

Multimedia coverage

A scientist talks to other scientists and lab organisms on a conference call.

Conducting science during a pandemic

Covid-19

February 01, 2021

While the institutional challenges presented by COVID-19 have been significant, Whitehead Institute scientists have responded with determination and focused innovation.

Head and shoulders photo of Silvi Rouskin

AudioHelicase Podcast: Silvi Rouskin on solving the structure of the coronavirus genome

Diseases

Infectious disease

October 13, 2020

In this episode of AudioHelicase Podcast, Whitehead Fellow Silvi Rouskin discusses her research on solving the structure of the novel coronavirus's RNA genome, with the goal of revealing weak points in the virus’s gene regulation that new drugs could potentially target.

Composite image of three people in a video conference above a map of the world overlaid with an illustration of the coronavirus.

COVID-19 scientific leaders share expertise in new MIT class

Covid-19

September 08, 2020

A new MIT course on the COVID-19 pandemic, available to the public online, brings together top COVID-19 experts to educate students on up-to-date pandemic science.

AudioHelicase podcast: Treatments for COVID-19 taking root in plant science

Covid-19

September 02, 2020

Whitehead Institute Member Jing-Ke Weng on the role of plant biology in stopping the pandemic.

Whitehead Fellow Kipp Weiskopf awarded grant to investigate treatments for COVID-19

Covid-19

May 18, 2020

Weiskopf will be studying how existing FDA-approved drugs could be repurposed to reduce the severity and mortality of the disease.